Resumen CHAVERRI-FERNANDEZ, José Miguel et al. The risk of treatment-induced QT
interval prolongation. Farm Hosp.[online]. 2022, vol. 46, n. 3, pp. 116-120. Epub 11-Jul …

Objective QT interval prolongation can increase patients' hospital stay and mortality rate.
This study aims to determine the incidence of drug-induced QT interval prolongation and …

Purpose Prolonged QT interval may lead to a lethal form of arrhythmia, torsades de pointes
(TdP), which is associated with cardiovascular mortality. Therefore, we aimed to identify …

Background Cardiac arrest due to torsades de pointes (TdP) is a rare but catastrophic event
in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval …

Background: QT interval prolongation is an important risk factor for sudden cardiac death.
Certain drugs are known to prolong the QT interval and thus should be avoided in most …

Background: QT interval prolongation carries an increased risk of torsade de pointes and
death. Aim: We sought to determine the prevalence of QT prolongation in medical inpatients …

Background: Hospitalized patients are at risk for torsades de pointes (TdP), due to multiple
risk factors and receipt of QT-prolonging drugs. A reliable method of identifying patients at …

Background: A prolonged QTc interval on electrocardiography is often used as a surrogate
marker for ventricular arrhythmia. Medications that can prolong the QTc interval may …

Background Numerous drugs prolong the QTc interval on the ECG and potentially increase
the risk of cardiac arrhythmia. This risk is clinically relevant in patients with additional risk …

QTc prolongation has a high prevalence of and is associated with increased all-cause
mortality. Nonetheless, QTc prolonging medications are often used during patient …